8-K: Kimberly-Clark Forms Strategic Joint Venture with Suzano, Divesting Majority Stake in International Tissue Business for $1.7 Billion

Kimberly-Clark announced a strategic partnership with Suzano S.A. to form a joint venture for its International Family Care and Professional (IFP) business, receiving approximately $1.7 billion for a 51% stake and sharpening its focus on higher-growth segments.

Summary

• Kimberly-Clark Corporation (KMB) has entered into an agreement with Suzano S.A. (Suzano) to form a joint venture, creating a new international company for consumer tissue and professional products.
• Kimberly-Clark will divest a 51% interest in its global International Family Care and Professional (IFP) business to Suzano International Holding B.V., a wholly-owned subsidiary of Suzano.
• The purchase price for the 51% interest is approximately $1.7 billion, subject to certain post-closing adjustments.
• Kimberly-Clark will retain a 49% interest in the newly formed company, Kimberly-Clark IFP NewCo B.V.
• The IFP business contributed to the venture encompasses sales in over 70 countries, 22 manufacturing facilities, and approximately 9,000 employees, generating about $3.3 billion in net sales in 2024.
• The implied current enterprise value for the business is approximately $3.4 billion.
• The new entity will own IFP's more than 40 regional brands, while Kimberly-Clark's five global brands (Scott, Kleenex, Viva, WypAll, and Kimberly-Clark Professional) will be licensed to the venture under a long-term agreement.
• Kimberly-Clark's interests in Mexico and its joint venture in South Korea are excluded from this transaction.
• The transaction is expected to be approximately $0.30-$0.40 dilutive to Adjusted Earnings Per Share in the first full year following close, assuming Kimberly-Clark returns the initial cash proceeds to shareholders through share repurchases.
• Suzano will have an option to purchase Kimberly-Clark's remaining 49% ownership interest at certain specified times and conditions, based on an agreed valuation framework.

Sentiment

Score: 7

Explanation: The announcement is strategically positive for Kimberly-Clark, enabling a focus on higher-margin businesses and generating substantial cash for shareholder returns. However, the immediate dilutive effect on EPS and the extended closing timeline introduce some near-term financial and operational uncertainties.

Positives

• Creates a preeminent international tissue and professional products company with significant new operational efficiency opportunities, expected to reduce total delivered product costs.
• Sharpens Kimberly-Clark's 'Powering Care' focus on proprietary, 'right to win' spaces, shifting its portfolio towards higher growth and higher margin businesses (North America and International Personal Care).
• Upon completion, approximately two-thirds of Kimberly-Clark's net revenues will come from personal care categories, improving its long-term growth trajectory, profitability, and returns on investment.
• Optimizes value for the IFP business, expected to create more value for shareholders than Kimberly-Clark could achieve running IFP on its own.
• Kimberly-Clark will receive meaningful upfront cash proceeds (approximately $1.7 billion) that it expects to return to shareholders through share repurchases following the close.
• Improves Kimberly-Clark's cost management by reducing exposure to more volatile input costs, enhancing its ability to deliver more predictable and consistent margins and profit growth.
• Strengthens the strategic partnership with Suzano, the world's largest fiber manufacturer, contributing to a more efficient and effective global supply chain.

Negatives

• The transaction is expected to be approximately $0.30-$0.40 dilutive to Adjusted Earnings Per Share in the first full year following close, including the company's expectation to return cash proceeds to shareholders.

Risks

• Failure to satisfy any of the conditions to the proposed transaction on a timely basis or at all.
• Occurrence of events that may give rise to a right of one or both parties to terminate the definitive agreements.
• Adverse effects on Kimberly-Clark's common stock market price and operating results due to a failure to complete the proposed transaction in the anticipated timeframe or at all.
• Negative effects of the pendency or consummation of the proposed transaction on Kimberly-Clark's market price and operating results.
• Risk of litigation or regulatory actions.
• Possibility that Kimberly-Clark may not fully realize the projected benefits of the proposed transaction within the expected timeframe or at all.
• Business disruption during the pendency of or following the proposed transaction.
• Diversion of management time from ongoing business operations due to the proposed transaction.
• Risk of any unexpected costs or expenses resulting from the proposed transaction.
• Risk that the proposed transaction and its announcement or Kimberly-Clark's strategy generally could have an adverse effect on the ability of the Corporation or the new joint venture to retain customers and retain and hire key personnel and maintain relationships with customers, suppliers, employees, stockholders, and other business relationships and on its operating results and business generally.
• The effects of developments related to tariffs and proposed increases in tariffs on imported goods and the impacts it may have on Kimberly-Clark's operations and financial results.

Future Outlook

The transaction is expected to close in mid-2026, contingent on regulatory approvals, completion of pre-closing reorganization, and employee consultations. Kimberly-Clark anticipates classifying the IFP businesses as discontinued operations in its financial disclosures starting with its second-quarter earnings results. The company plans to return the initial cash proceeds from the transaction to shareholders through share repurchases. Strategically, Kimberly-Clark expects the transaction to improve its long-term growth trajectory, profitability, and returns on investment by focusing on higher-growth, higher-margin personal care categories.

Management Comments

• Mike Hsu, Chairman and CEO: "This transaction is a powerful step forward in the transformation strategy we laid out last year... we are excited to expand our partnership with Suzano and focus Kimberly-Clark's portfolio on our higher growth, higher margin businesses. Together, this positions each business to move forward with clarity and seize the tremendous opportunities ahead."
• Jeff Melucci, Chief Strategy, Business Development and Administrative Officer: "Suzano is a leader in its field, whose deep industrial manufacturing and fiber expertise complement Kimberly-Clark's leading brands and world-class commercial capabilities."
• Nelson Urdaneta, Chief Financial Officer: "This transaction generates immediate returns and long-term shareholder value as we capture the upside from a stronger international tissue and professional franchise and accelerate growth and innovation at Kimberly-Clark."
• Nelson Urdaneta, Chief Financial Officer: "As the largest fiber manufacturer in the world, Suzano has been an instrumental strategic partner in our efforts to build a more efficient and effective global supply chain. We look forward to strengthening that partnership in the years to come."

Industry Context

This transaction reflects a broader trend among consumer goods companies to streamline portfolios, divest non-core or lower-margin assets, and focus on segments with higher growth potential and profitability. By partnering with Suzano, a leading pulp supplier, Kimberly-Clark aims to leverage vertical integration benefits and optimize supply chain costs in the tissue and professional products segment, while shifting its own core business towards higher-margin personal care products. This move allows Kimberly-Clark to adapt to evolving market dynamics and competitive pressures by concentrating resources on its most profitable and strategically aligned brands.

Corporate Governance

Stakeholder Impact

• Shareholders: Expected to benefit from a sharpened strategic focus on higher-growth, higher-margin businesses and the return of capital through share repurchases, though an initial dilutive effect on Adjusted EPS is anticipated.
• Employees: Approximately 9,000 employees of the IFP business will transition to the new joint venture, subject to employee consultation requirements.
• Customers: The new venture aims to reduce total delivered product costs and supply both branded and private label offerings, potentially benefiting consumers and customers.
• Suppliers: The transaction could impact existing supplier relationships for the IFP business as the new joint venture seeks operational efficiencies and leverages Suzano's fiber expertise.

Next Steps

• Completion of certain aspects of the pre-Closing reorganization of the IFP business.
• Satisfaction or waiver of customary closing conditions, including receipt of required regulatory approvals.
• Completion of certain employee consultation requirements.
• Kimberly-Clark and Suzano will enter into a joint venture agreement (JVA) at the closing of the transaction.
• Kimberly-Clark expects to return the initial cash proceeds from the transaction to shareholders through share repurchases following the close.
• Kimberly-Clark anticipates classifying the IFP businesses included in the transaction as discontinued operations within its financial disclosures beginning with its second quarter earnings results (expected by early August).

Key Dates

Recommendation

Keywords

Kimberly-Clark, KMB, Suzano, SUZ, joint venture, divestiture, tissue products, personal care, consumer goods, strategic partnership, corporate restructuring, share repurchase, international business, pulp and paper